Loading company…
UK provider of early-stage drug development, drug surveillance for sport and blood-typing reagent services.
Founded in 2007 and headquartered in Fordham, UK, Quotient Bioscience Group Limited provides analytical and safety evaluation services for bioscience and sport. Its businesses cover early-stage drug development for pharmaceutical and biotechnology companies, drug surveillance for sport, and critical reagents used for blood typing. TA Associates invested GBP 35 million in July 2008, and Permira acquired a majority stake in 2019.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in